[Effect of iron concentrations on the DNA-degradation reaction by bleomycin].
DNA-degradation reaction by bleomycin was conducted with form I of SV40 DNA as the substrate under "iron-limited conditions" and "iron-sufficient conditions". For "iron-limited conditions", the iron ions in reaction mixtures were derived from contaminant iron in the bleomycin preparation, the molar ratio of bleomycin/iron being 1/0.05. For "iron-sufficient conditions", Fe(II) was added to reaction mixtures to attain the molar ratio of bleomycin/iron at 1/1 to 1/29. DNA-degradation reaction by Fe(II) without bleomycin, or "Fe(II) alone", was also run for comparison. In any case, the reaction was allowed to proceed at such low rates that other products than form II and form III, due to further fragmentation, were negligible. The mass of DNA in each form was quantitatively determined by spectrofluorometry after agarose gel electrophoresis and staining with ethidium bromide. "Iron-limited conditions" and "iron-sufficient conditions" showed similar reaction characteristics as follows. As form I decreased with incubation time, form II increased faster than form III, hit a plateau (ca. 65% of total DNA) and decreased gradually thereafter. Form III kept increasing throughout the incubation. The reaction was dependent on incubation time and on doses of both bleomycin and Fe(II) but rather independent of temperature. The reaction was inhibited by acidic pH, Tiron (a specific chelator of iron) and Cu(II) but not EDTA. Octanucleotides with specific base sequence inhibited the reaction. DNA-degradation reaction by "Fe(II) alone" showed different characteristics as follows. The reaction proceeded rapidly at first, but ceased within 2 minutes. The extent of reaction was dependent on dose of Fe(II). The reaction product was form II accompanied by little amount of form III. The reaction was highly dependent on temperature, inhibited by EDTA, and not inhibited by Cu(II) and acidic pH. Octanucleotides, irrespective of their base sequences, inhibited the reaction.
Asakura
H
H
Okubo
H
H
Hori
M
M
D001483:Base Sequence; D001761:Bleomycin / Q000494:pharmacology*; D003300:Copper / Q000494:pharmacology; D004279:DNA, Viral / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004492:Edetic Acid / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007477:Ions; D007501:Iron / Q000494:pharmacology*; D013539:Simian virus 40 / Q000378:metabolism; D013696:Temperature; D013997:Time Factors
D004279:DNA, Viral; D007477:Ions; D001761:Bleomycin; D003300:Copper; D004492:Edetic Acid; D007501:Iron